Registro:

Referencias:

• Ahima, R.S., Flier, J.S., Leptin (2000) Ann. Rev. Physiol., 62, pp. 413-437
• Asa, S.L., Kelly, M.A., Grandy, D.K., Low, M.J., Pituitary lactotroph adenomas develop after prolonged lactotroph hyperplasia in dopamine D2 receptor-deficient mice (1999) Endocrinology, 140, pp. 5348-5355
• Ben-Jonathan, N., Hugo, E.R., Brandebourg, T.D., LaPensee, C.R., Focus on prolactin as a metabolic hormone (2006) Trends Endocrinol. Metab., 17, pp. 110-116
• Beuckmann, C.T., Yanagisawa, M., Orexins: from neuropeptides to energy homeostasis and sleep/wake regulation (2002) J. Mol. Med., 80, pp. 329-342
• Bina, K.G., Cincotta, A.H., Dopaminergic agonists normalize elevated hypothalamic neuropeptide Y and corticotropin-releasing hormone, body weight gain, and hyperglycemia in ob/ob mice (2000) Neuroendocrinology, 71, pp. 68-78
• Bubser, M., Fadel, J.R., Jackson, L.L., Meador-Woodruff, J.H., Jing, D., Deutch, A.Y., Dopaminergic regulation of orexin neurons (2005) Eur. J. Neurosci., 21, pp. 2993-3001
• Catania, A., Airaghi, L., Colombo, G., Lipton, J.M., Alpha-melanocyte-stimulating hormone in normal human physiology and disease states (2000) Trends Endocrinol. Metab., 11, pp. 304-308
• Chen, P., Smith, M.S., Regulation of hypothalamic neuropeptide Y messenger ribonucleic acid expression during lactation: role of prolactin (2004) Endocrinology, 145, pp. 823-829
• Chen, C.L., Dionne, F.T., Roberts, J.L., Regulation of the pro-opiomelanocortin mRNA levels in rat pituitary by dopaminergic compounds (1983) Proc. Natl. Acad. Sci. USA, 80, pp. 2211-2215
• Cheung, C.C., Clifton, D.K., Steiner, R.A., Proopiomelanocortin neurons are direct targets for leptin in the hypothalamus (1997) Endocrinology, 138, pp. 4489-4492
• Cone, R.D., The central melanocortin system and energy homeostasis (1999) Trends Endocrinol. Metab., 10, pp. 211-216
• Cone, R.D., Cowley, M.A., Butler, A.A., Fan, W., Marks, D.L., Low, M.J., The arcuate nucleus as a conduit for diverse signals relevant to energy homeostasis (2001) Int. J. Obes. Relat. Metab. Disord., 25 (SUPPL. 5), pp. S63-S67
• Cote, T.E., Felder, R., Kebabian, J.W., Sekura, R.D., Reisine, T., Affolter, H.U., D-2 dopamine receptor-mediated inhibition of pro-opiomelanocortin synthesis in rat intermediate lobe. Abolition by pertussis toxin or activators of adenylate cyclase (1986) J. Biol. Chem., 261, pp. 4555-4561
• Cowley, M.A., Smart, J.L., Rubinstein, M., Cerdan, M.G., Diano, S., Horvath, T.L., Cone, R.D., Low, M.J., Leptin activates anorexigenic POMC neurons through a neural network in the arcuate nucleus (2001) Nature, 411, pp. 480-484
• Cristina, C., Diaz-Torga, G., Baldi, A., Gongora, A., Rubinstein, M., Low, M.J., Becu-Villalobos, D., Increased pituitary vascular endothelial growth factor-A in dopaminergic D2 receptor knockout female mice (2005) Endocrinology, 146, pp. 2952-2962
• Cristina, C., Diaz-Torga, G., Gongora, A., Guida, M.C., Perez-Millan, M.I., Baldi, A., Becu-Villalobos, D., Fibroblast growth factor-2 in hyperplastic pituitaries of D2R knockout female mice (2007) Am. J. Physiol. Endocrinol. Metab., 293, pp. E1341-E1351
• da Silva, A.A., Kuo, J.J., Hall, J.E., Role of hypothalamic melanocortin 3/4-receptors in mediating chronic cardiovascular, renal, and metabolic actions of leptin (2004) Hypertension, 43, pp. 1312-1317
• Dalal, M.A., Schuld, A., Pollmacher, T., Lower CSF orexin A (hypocretin-1) levels in patients with schizophrenia treated with haloperidol compared to unmedicated subjects (2003) Mol. Psychiatry, 8, pp. 836-837
• de Lecea, L., Kilduff, T.S., Peyron, C., Gao, X., Foye, P.E., Danielson, P.E., Fukuhara, C., Sutcliffe, J.G., The hypocretins: hypothalamus-specific peptides with neuroexcitatory activity (1998) Proc. Natl. Acad. Sci. USA, 95, pp. 322-327
• Diaz-Torga, G., Feierstein, C., Libertun, C., Gelman, D., Kelly, M.A., Low, M.J., Rubinstein, M., Becu-Villalobos, D., Disruption of the D2 dopamine receptor alters GH and IGF-I secretion and causes dwarfism in male mice (2002) Endocrinology, 143, pp. 1270-1279
• Elias, C.F., Saper, C.B., Maratos-Flier, E., Tritos, N.A., Lee, C., Kelly, J., Tatro, J.B., Elmquist, J.K., Chemically defined projections linking the mediobasal hypothalamus and the lateral hypothalamic area (1998) J. Comp. Neurol., 402, pp. 442-459
• Fadel, J., Deutch, A.Y., Anatomical substrates of orexin-dopamine interactions: lateral hypothalamic projections to the ventral tegmental area (2002) Neuroscience, 111, pp. 379-387
• Fan, W., Dinulescu, D.M., Butler, A.A., Zhou, J., Marks, D.L., Cone, R.D., The central melanocortin system can directly regulate serum insulin levels (2000) Endocrinology, 141, pp. 3072-3079
• Fetissov, S.O., Meguid, M.M., On dopamine, D2 receptor, and Taq1A polymorphism in obesity and anorexia (2009) Nutrition, 25, pp. 132-133
• Fetissov, S.O., Meguid, M.M., Sato, T., Zhang, L.H., Expression of dopaminergic receptors in the hypothalamus of lean and obese Zucker rats and food intake (2002) Am. J. Physiol. Regul. Integr. Comp. Physiol., 283, pp. R905-R910
• Freemark, M., Fleenor, D., Driscoll, P., Binart, N., Kelly, P.A., Body weight and fat deposition in prolactin receptor-deficient mice (2001) Endocrinology, 142, pp. 532-537
• Garcia, M.C., Lopez, M., Gualillo, O., Seoane, L.M., Dieguez, C., Senaris, R.M., Hypothalamic levels of NPY, MCH, and prepro-orexin mRNA during pregnancy and lactation in the rat: role of prolactin (2003) FASEB J., 17, pp. 1392-1400
• Garcia-Tornadu, I., Rubinstein, M., Gaylinn, B.D., Hill, D., Arany, E., Low, M.J., Diaz-Torga, G., Becu-Villalobos, D., GH in the dwarf dopaminergic D2 receptor knockout mouse: somatotrope population, GH release, and responsiveness to GH-releasing factors and somatostatin (2006) J. Endocrinol., 190, pp. 611-619
• Haynes, W.G., Morgan, D.A., Djalali, A., Sivitz, W.I., Mark, A.L., Interactions between the melanocortin system and leptin in control of sympathetic nerve traffic (1999) Hypertension, 33, pp. 542-547
• Hillebrand, J.J., de Wied, D., Adan, R.A., Neuropeptides, food intake and body weight regulation: a hypothalamic focus (2002) Peptides, 23, pp. 2283-2306
• Hurley, D.L., Birch, D.V., Almond, M.C., Estrada, I.J., Phelps, C.J., Reduced hypothalamic neuropeptide Y expression in growth hormone- and prolactin-deficient Ames and Snell dwarf mice (2003) Endocrinology, 144, pp. 4783-4789
• Kamiji, M.M., Inui, A., Neuropeptide y receptor selective ligands in the treatment of obesity (2007) Endocr. Rev., 28, pp. 664-684
• Kastin, A.J., Redding, T.W., Hall, R., Besser, G.M., Schally, A.V., Lipid mobilizing hormones of the hypothalamus and pituitary (1975) Pharmacol. Biochem. Behav., 3, pp. 121-126
• Kelly, M.A., Rubinstein, M., Asa, S.L., Zhang, G., Saez, C., Bunzow, J.R., Allen, R.G., Low, M.J., Pituitary lactotroph hyperplasia and chronic hyperprolactinemia in dopamine D2 receptor-deficient mice (1997) Neuron, 19, pp. 103-113
• Kelly, M.A., Rubinstein, M., Zhang, G., Saez, C., Bunkenburg, B., Zhang, G., Saez, C., Low, M.J., Locomotor activity in D2 dopamine receptor-deficient mice is determined by gene dosage, genetic background, and developmental adaptations (1998) J. Neurosci., 18, pp. 3470-3479
• Kishi, T., Aschkenasi, C.J., Lee, C.E., Mountjoy, K.G., Saper, C.B., Elmquist, J.K., Expression of melanocortin 4 receptor mRNA in the central nervous system of the rat (2003) J. Comp. Neurol., 457, pp. 213-235
• Leibowitz, S.F., Brain monoamines and peptides: role in the control of eating behavior (1986) Fed. Proc., 45, pp. 1396-1403
• Lopez, M., Lage, R., Tung, Y.C., Challis, B.G., Varela, L., Virtue, S., O'Rahilly, S., Coll, A.P., Orexin expression is regulated by alpha-melanocyte-stimulating hormone (2007) J. Neuroendocrinol., 19, pp. 703-707
• Lubkin, M., Stricker-Krongrad, A., Independent feeding and metabolic actions of orexins in mice (1998) Biochem. Biophys. Res. Commun., 253, pp. 241-245
• Luukkaa, V., Savontaus, E., Rour, J., Virtanen, K.A., Boss, O., Huhtaniemi, I., Koulu, M., Huupponon, R., Effects of estrous cycle and steroid replacement on the expression of leptin and uncoupling proteins in adipose tissue in the rat (2001) Gynecol. Endocrinol., 15, pp. 103-112
• Manzanares, J., Toney, T.W., Tian, Y., Eaton, M.J., Moore, K.E., Lookingland, K.J., Sexual differences in the activity of periventricular-hypophysial dopaminergic neurons in rats (1992) Life Sci., 51, pp. 995-1001
• Monda, M., Viggiano, A.N., Viggiano, A., Viggiano, E., Lanza, A., De, L.V., Hyperthermic reactions induced by orexin A: role of the ventromedial hypothalamus (2005) Eur. J. Neurosci., 22, pp. 1169-1175
• Naef, L., Woodside, B., Prolactin/leptin interactions in the control of food intake in rats (2007) Endocrinology, 148, pp. 5977-5983
• Peruzzo, B., Pastor, F.E., Blazquez, J.L., Schobitz, K., Pelaez, B., Amat, P., Rodriguez, E.M., A second look at the barriers of the medial basal hypothalamus (2000) Exp. Brain Res., 132, pp. 10-26
• Pijl, H., Reduced dopaminergic tone in hypothalamic neural circuits: expression of a "thrifty" genotype underlying the metabolic syndrome? (2003) Eur. J. Pharmacol., 480, pp. 125-131
• Ramos, E.J., Meguid, M.M., Campos, A.C., Coelho, J.C., Neuropeptide Y, alpha-melanocyte-stimulating hormone, and monoamines in food intake regulation (2005) Nutrition, 21, pp. 269-279
• Sahu, A., Leptin signaling in the hypothalamus: emphasis on energy homeostasis and leptin resistance (2003) Front. Neuroendocrinol., 24, pp. 225-253
• Sakurai, T., Amemiya, A., Ishii, M., Matsuzaki, I., Chemelli, R.M., Tanaka, H., Williams, S.C., Yanagisawa, M., Orexins and orexin receptors: a family of hypothalamic neuropeptides and G protein-coupled receptors that regulate feeding behavior (1998) Cell, 92, pp. 573-585
• Samson, W.K., Gosnell, B., Chang, J.K., Resch, Z.T., Murphy, T.C., Cardiovascular regulatory actions of the hypocretins in brain (1999) Brain Res., 831, pp. 248-253
• Sato, T., Meguid, M.M., Fetissov, S.O., Chen, C., Zhang, L., Hypothalamic dopaminergic receptor expressions in anorexia of tumor-bearing rats (2001) Am. J. Physiol. Regul. Integr. Comp. Physiol., 281, pp. R1907-R1916
• Sauve, D., Woodside, B., The effect of central administration of prolactin on food intake in virgin female rats is dose-dependent, occurs in the absence of ovarian hormones and the latency to onset varies with feeding-regimen (1996) Brain Res., 729, pp. 75-81
• Sauve, D., Woodside, B., Neuroanatomical specificity of prolactin-induced hyperphagia in virgin female rats (2000) Brain Res., 868, pp. 306-314
• Seeley, R.J., Yagaloff, K.A., Fisher, S.L., Burn, P., Thiele, T.E., van Dijk, G., Baskin, D.G., Schwartz, M.W., Melanocortin receptors in leptin effects (1997) Nature, 390, p. 349
• Silveyra, P., Catalano, P.N., Lux-Lantos, V., Libertun, C., Impact of proestrous milieu on expression of orexin receptors and prepro-orexin in rat hypothalamus and hypophysis: actions of Cetrorelix and Nembutal (2007) Am. J. Physiol. Endocrinol. Metab., 292, pp. E820-E828
• Taheri, S., Zeitzer, J.M., Mignot, E., The role of hypocretins (orexins) in sleep regulation and narcolepsy (2002) Annu. Rev. Neurosci., 25, pp. 283-313
• Terry, P., Gilbert, D.B., Cooper, S.J., Dopamine receptor subtype agonists and feeding behavior (1995) Obes. Res., 3 (SUPPL. 4), pp. 515S-523S
• Trivedi, P., Yu, H., MacNeil, D.J., Van der Ploeg, L.H., Guan, X.M., Distribution of orexin receptor mRNA in the rat brain (1998) FEBS Lett., 438, pp. 71-75

Citas:

---------- APA ----------

---------- CHICAGO ----------

---------- MLA ----------

---------- VANCOUVER ----------